PGP and major depressive disorder: Hyperactivity of the hypothalamus-pituitary-adrenal (HPA) axis is one of the most consistent biological hallmarks of MDD, and it has been suggested that increased penetration of glucocorticoids into the brain as a result of P-gp inhibition may contribute to normalization of HPA axis hyperactivity in MDD (O'Brien et al., 2012).